Birdwatch Archive

Birdwatch Note

2023-03-14 13:25:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Ivermectin is an anti-parasitic drug approved in humans for treatment of certain tropical diseases. This tweet alludes that taking this medicine will kill you, that is factually incorrect. https://www.ama-assn.org/delivering-care/public-health/what-ivermectin

Written by 2F92095A1B5A4C0260E486FC5184399B66B781D447E6DC18E23359F7428AFAC1
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1635623681522114564

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1635633252688953344
  • noteId - 1635633252688953344
  • participantId -
  • noteAuthorParticipantId - 2F92095A1B5A4C0260E486FC5184399B66B781D447E6DC18E23359F7428AFAC1 Participant Details
  • createdAtMillis - 1678800330693
  • tweetId - 1635623681522114564
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Ivermectin is an anti-parasitic drug approved in humans for treatment of certain tropical diseases. This tweet alludes that taking this medicine will kill you, that is factually incorrect. https://www.ama-assn.org/delivering-care/public-health/what-ivermectin

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-14 13:25:30 UTC
(1678800330693)		 2023-03-14 15:41:01 UTC
(1678808461400)		 CURRENTLY_RATED_NOT_HELPFUL 2023-03-15 05:09:59 UTC
(1678856999448)		 NEEDS_MORE_RATINGS 2023-03-14 15:41:01 UTC
(1678808461400)		 CURRENTLY_RATED_NOT_HELPFUL

Note Ratings

rated at rated by
2023-03-14 22:00:46 -0500 Rating Details
2023-03-14 20:05:08 -0500 Rating Details
2023-03-14 19:27:35 -0500 Rating Details
2023-03-14 17:41:31 -0500 Rating Details
2023-03-14 17:40:18 -0500 Rating Details
2023-03-14 16:41:36 -0500 Rating Details
2023-03-14 16:19:37 -0500 Rating Details
2023-03-14 16:09:45 -0500 Rating Details
2023-03-14 15:49:42 -0500 Rating Details
2023-03-14 15:36:05 -0500 Rating Details
2023-03-14 13:25:17 -0500 Rating Details
2023-03-14 13:24:32 -0500 Rating Details
2023-03-14 12:57:28 -0500 Rating Details
2023-03-14 11:29:04 -0500 Rating Details
2023-03-14 11:17:48 -0500 Rating Details
2023-03-14 10:52:51 -0500 Rating Details
2023-03-14 10:52:49 -0500 Rating Details
2023-03-14 10:44:42 -0500 Rating Details
2023-03-14 10:41:41 -0500 Rating Details
2023-03-14 10:36:05 -0500 Rating Details
2023-03-14 10:12:36 -0500 Rating Details
2023-03-14 09:39:28 -0500 Rating Details
2023-03-14 09:33:06 -0500 Rating Details
2023-03-14 09:27:30 -0500 Rating Details
2023-03-14 09:16:31 -0500 Rating Details
2023-03-14 09:08:39 -0500 Rating Details
2023-03-14 09:08:01 -0500 Rating Details
2023-03-14 08:55:09 -0500 Rating Details
2023-03-14 08:51:03 -0500 Rating Details
2023-03-14 08:45:46 -0500 Rating Details
2023-03-14 08:36:19 -0500 Rating Details
2023-03-14 08:31:48 -0500 Rating Details
2023-03-15 13:34:53 -0500 Rating Details
2023-03-15 05:53:20 -0500 Rating Details
2023-03-15 01:48:11 -0500 Rating Details
2023-03-15 00:21:18 -0500 Rating Details
2023-03-15 00:21:08 -0500 Rating Details
2023-03-14 22:44:40 -0500 Rating Details
2023-03-15 23:04:30 -0500 Rating Details
2023-03-14 08:51:03 -0500 Rating Details
2023-03-14 16:09:45 -0500 Rating Details
2023-03-14 17:41:31 -0500 Rating Details
2023-03-15 01:48:11 -0500 Rating Details
2023-03-14 16:41:36 -0500 Rating Details
2023-03-15 23:04:30 -0500 Rating Details
2023-03-14 20:05:08 -0500 Rating Details
2023-03-14 13:25:17 -0500 Rating Details
2023-03-14 09:16:31 -0500 Rating Details
2023-03-15 00:21:08 -0500 Rating Details
2023-03-14 22:00:46 -0500 Rating Details
2023-03-14 13:24:32 -0500 Rating Details
2023-03-14 08:36:19 -0500 Rating Details
2023-03-14 11:17:48 -0500 Rating Details
2023-03-14 10:12:36 -0500 Rating Details
2023-03-14 09:33:06 -0500 Rating Details
2023-03-15 00:21:18 -0500 Rating Details
2023-03-14 10:41:41 -0500 Rating Details
2023-03-14 08:45:46 -0500 Rating Details
2023-03-14 08:55:09 -0500 Rating Details
2023-03-15 13:34:53 -0500 Rating Details
2023-03-14 19:27:35 -0500 Rating Details
2023-03-14 17:40:18 -0500 Rating Details
2023-03-14 15:49:42 -0500 Rating Details
2023-03-14 12:57:28 -0500 Rating Details
2023-03-14 09:27:30 -0500 Rating Details
2023-03-14 10:44:42 -0500 Rating Details
2023-03-15 05:53:20 -0500 Rating Details
2023-03-14 10:52:51 -0500 Rating Details
2023-03-14 22:44:40 -0500 Rating Details
2023-03-14 09:08:01 -0500 Rating Details
2023-03-14 15:36:05 -0500 Rating Details
2023-03-14 10:52:49 -0500 Rating Details
2023-03-14 09:39:28 -0500 Rating Details
2023-03-14 09:08:39 -0500 Rating Details
2023-03-14 16:19:37 -0500 Rating Details
2023-03-14 11:29:04 -0500 Rating Details
2023-03-14 08:31:48 -0500 Rating Details
2023-03-14 10:36:05 -0500 Rating Details